摘要
王瑞平教授认为大肠癌病机复杂、临床表现多变,中医药在防治其发生发展方面具有重要的作用,而临证之时单一治法难以兼顾复杂的病机,应多法综合,多方合一,以组复方,通过选用小方及经验药组使药味精简,能够提高患者的依从性,符合临床实际。
Professor WANG Ruiping believes that the pathogenesis of colorectal cancer is complex and the clinical manifestations are changeable. TCM plays an important role in the prevention and treatment of colorectal cancer. Single treatment is difficult to take into account the complex pathogenesis,so the combination of multiple treatment and multiple prescriptions to form a compound is necessary. By choosing simple prescriptions and empirical drug combinations to streamline the drug taste,can improve patient compliance and it is in line with clinical practice.
引文
[1]SIEGEL R,MA J,ZOU Z,et al.Cancer statistics 2014[J].CA Cancer J Clin,2014,64(1):9~29
[2]陈歆妮.克瘤丸治疗晚期大肠癌的临床观察及其对血清VEGF的影响[D].南京:南京中医药大学,2011
[3]谢鸣.方剂与复方的名实辨析[J].中国实验方剂学杂志,2015,21(22):140~144
[4]蒋成婷,周德生,陈大舜,等.复方配伍与药物精简应用[J].中医杂志,2017,58(9):796~799
[5]朱学明.论癌症治疗当用复方和法[A].第三届国际中医、中西医结合肿瘤学术交流大会暨第十二届全国中西医结合肿瘤学术大会论文汇编[C].中国中西医结合学会肿瘤专业委员会,2010
[6]Ishihara S,Nishikawa T,Tanaka T,et al.Prognostic impact of tumor location in stage IV colon cancer:a propensity score analysis in a multicenter study[J].Int J Surg,2014,12(9):925~930